ASGR1 and metabolic dysfunction-associated steatotic liver disease: Additionally, findings from RNA-sequencing data (GSE126848) [47] suggest significant reduction in ASGR1 gene expression as the liver progresses from an obese state to NAFLD and NASH (Fig. 5K).